胰腺局部Mas调节葡萄糖稳态及其分子机制研究

基本信息
批准号:81300726
项目类别:青年科学基金项目
资助金额:23.00
负责人:张雪莲
学科分类:
依托单位:首都医科大学
批准年份:2013
结题年份:2016
起止时间:2014-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:刘薇,陈一文,尚军,曹琪玥,陈延云
关键词:
葡萄糖转运体2丝裂原活化蛋白激酶Mas囊性纤维化跨膜通道调节因子葡萄糖稳态
结项摘要

The actions of angiotensin - (1-7)-Mas receptor axis counterbalance those of Ang-Ⅱ. Our data showed Mas protein was detected in both endocrine tissue and exocrine tissue of pancreas. The changes of Mas in islets were detected earlier than ACE2 in OLETF rat in pancreas with diabetes. The binding of Ang-(1-7) and Mas can stimulate the islet cells to secrete insulin, and caused a significant stimulation of mRNA and protein expression of GLUT-2. On the contrary, our result showed a reduction in TGF-β1 mRNA and protein expression. Meantime, we establish the evidence for expression of CFTR protein in mouse pancreatic islets. These results provide the evidence for putative role of Mas receptor in pancreas. However, the possible molecular mechanism of Mas receptor in glucose homeostasis in pacreas is unclear. We hypothesis that Mas can regulate the glucose homeostasis, probably due to its enhancing the ability to intake glucose, also regulate MAPKs and CFTR pathway stimulated by TGF-β1. Using the animal model, we aimed to investigate the changes of glucose homeostasis in Mas-deficient mice. On the other hand, in vivo and in vitro study, after the cells were preincubated with Ang-(1-7) or A779, we investigate the effect of Mas on insulin secretion. Also we investigate the potential role of Mas on calcium pathway regulated by GLUT-2 and MAPKs and CFTR pathway stimulated by TGF-β1. These findings might provide a new vision on pancreatic disease .

Ang-(1-7)通过Mas在体内发挥拮抗血管紧张素-Ⅱ作用。我们研究发现Mas在大鼠胰腺表达,OLETF糖尿病大鼠胰岛细胞Mas的改变先于ACE2变化。Mas与Ang-(1-7)结合可促进胰岛细胞分泌胰岛素、上调GLUT-2表达、减少TGF-β1生成,胰岛细胞表达CFTR。但胰腺局部Mas对葡萄糖糖稳态调节的作用机制尚不清楚。本课题假设:胰腺局部Mas参与葡萄糖稳态调节,并可能通过调控胰岛细胞葡萄糖摄取、MAPK通路及离子通道等发挥作用。本课题拟观察Mas敲除小鼠糖代谢及胰岛素水平的改变;经Mas激动剂Ang(1-7)及其拮抗剂A779干预,体内、体外研究探讨Mas对胰岛细胞胰岛素分泌、GLUT-2调控的Ca2+ 通道、TGF-β1激活的MAPKs(ERK1/2, SAPK/JNK, and p38 MAPK)及CFTR离子通道的影响,以论证假说,并为研究胰腺疾病的潜在方向提供线索。

项目摘要

Ang-(1-7)通过Mas在体内发挥拮抗血管紧张素-Ⅱ作用。但胰腺局部Mas对葡萄糖糖稳态调节的作用机制尚不清楚。本课题假设:胰腺局部Mas参与葡萄糖稳态调节,并可能通过调控胰岛细胞葡萄糖摄取、MAPK通路及离子通道等发挥作用。本课题观察糖尿病大鼠及Mas敲除小鼠糖代谢及胰岛素水平的改变;经Mas激动剂Ang(1-7)及其拮抗剂A779干预,体内、体外研究探讨Mas对胰岛细胞胰岛素分泌、GLUT-2调控的Ca2+通道、TGF-β1激活的MAPKs及CFTR离子通道的影响。我们研究发现Mas在大鼠胰腺表达,糖尿病大鼠胰岛细胞Mas的表达下降,Mas缺失鼠呈现糖耐量异常,Mas与Ang-(1-7)结合可促进胰岛细胞分泌胰岛素。胰岛细胞表达CFTR。胰腺局部Mas与糖代谢存在密切关系,可能通过葡萄糖转运、TGF-β1调控的CFTR离子通道等环节发挥作用,在葡萄糖稳态中可能具有良性调节作用,为研究胰腺疾病的潜在方向提供线索。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
2

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
3

跨社交网络用户对齐技术综述

跨社交网络用户对齐技术综述

DOI:10.12198/j.issn.1673 − 159X.3895
发表时间:2021
4

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

DOI:10.1016/j.intimp.2021.107374
发表时间:2021
5

基于SSVEP 直接脑控机器人方向和速度研究

基于SSVEP 直接脑控机器人方向和速度研究

DOI:10.16383/j.aas.2016.c150880
发表时间:2016

张雪莲的其他基金

相似国自然基金

1

重症胰腺炎胰腺局部ACE2-Ang(1-7)-Mas受体轴改变及其作用机制研究

批准号:81000187
批准年份:2010
负责人:王婧
学科分类:H0313
资助金额:20.00
项目类别:青年科学基金项目
2

脑血管稳态调节基因DCN分子机制研究

批准号:91439132
批准年份:2014
负责人:杨鹏远
学科分类:H0906
资助金额:90.00
项目类别:重大研究计划
3

地黄寡糖对2型糖尿病葡萄糖稳态的调节作用及机制研究

批准号:30472186
批准年份:2004
负责人:贾正平
学科分类:H3211
资助金额:8.00
项目类别:面上项目
4

益气活血中药对肠-脑-肝轴葡萄糖稳态调节系统功能影响的分子机制及药效物质基础研究

批准号:30973884
批准年份:2009
负责人:闻晓东
学科分类:H3202
资助金额:32.00
项目类别:面上项目